David Preiss

University of Oxford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Collaborators (11)

Kathleen Boyd

Reader

University of Glasgow

UNITED KINGDOM

View details

Lisa Holland

University of Oxford

UNITED KINGDOM

View details

Farah E Latif

Clinical Lecturer

Cardiff University

UNITED KINGDOM

View details

Michelle Goonasekera

University of Oxford

UNITED KINGDOM

View details

Ajay Gupta

Senior Clinical Lecturer

Queen Mary University of London

UNITED KINGDOM

View details

Alastair Gray

University of Oxford

UNITED KINGDOM

View details

Lisa Seekircher

Medical University of Innsbruck

AUSTRIA

View details

Richard Haynes

University of Oxford

UNITED KINGDOM

View details

Ruth Coleman

University of Oxford

UNITED KINGDOM

View details

Jonathan Emberson

Professor of Medical Statistics and Epidemiology

University of Oxford

UNITED KINGDOM

View details

Borislava Mihaylova

Professor of Health Economics

Queen Mary University of London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Preiss

Research Interests

Explore related searches

Contact this professor

Articles (10)

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial.

Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009–2017

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials.

Empagliflozin in Patients with Chronic Kidney Disease.

Effect of Fenofibrate Therapy on Laser Treatment for Diabetic Retinopathy: A Meta-Analysis of Randomized Controlled Trials

Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients.

Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar.

Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease.

Collaborators (11)

Kathleen Boyd

Lisa Holland

Farah E Latif

Michelle Goonasekera

Ajay Gupta

Alastair Gray

Lisa Seekircher

Richard Haynes

Ruth Coleman

Jonathan Emberson

Borislava Mihaylova

Make your next move.